• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验室止血检测报告:减少止血诊断中分析后错误的最后机会?

Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis?

机构信息

Department of Hematology, Institute of Clinical Pathology and Medical Research ICPMR, Westmead Hospital, SWAHS, Westmead, NSW, Australia.

出版信息

Clin Chem Lab Med. 2010 Mar;48(3):309-21. doi: 10.1515/CCLM.2010.061.

DOI:10.1515/CCLM.2010.061
PMID:20014957
Abstract

The advent of modern instrumentation, with associated improvements in test performance and reliability, together with appropriate internal quality control (IQC) and external quality assurance (EQA) measures, has led to substantial reductions in analytical errors within hemostasis laboratories. Unfortunately, the reporting of incorrect or inappropriate test results still occurs, perhaps even as frequently as in the past. Many of these cases arise due to a variety of events largely outside the control of the laboratories performing the tests. These events are primarily preanalytical, related to sample collection and processing, but can also include post-analytical events related to the reporting and interpretation of test results. The current report provides an overview of these events, as well as guidance for prevention or minimization. In particular, we propose several strategies for the post-analytical reporting of hemostasis assays, and how this may provide the final opportunity to prevent serious clinical errors in diagnosis. This report should be of interest to both the laboratory scientists working in hemostasis and clinicians that request and attempt to interpret the test results. Laboratory scientists are ultimately responsible for these test results, and there is a duty to provide both accurate and precise results to enable clinicians to manage patients appropriately and to avoid the need to recollect and retest. Also, clinicians will not be in a position to best diagnose and manage their patient unless they gain an appreciation of these issues.

摘要

现代仪器的出现,以及测试性能和可靠性的相关改进,加上适当的内部质量控制(IQC)和外部质量保证(EQA)措施,已经导致止血实验室中的分析误差大大减少。不幸的是,不正确或不适当的测试结果的报告仍然存在,甚至可能像过去一样频繁。这些情况中的许多是由于实验室测试之外的各种事件引起的。这些事件主要是与样本采集和处理相关的分析前事件,但也可能包括与测试结果的报告和解释相关的分析后事件。本报告概述了这些事件,并提供了预防或最小化这些事件的指导。特别是,我们提出了几种止血测定分析后的报告策略,以及这如何为预防诊断中的严重临床错误提供最后的机会。本报告应该对从事止血研究的实验室科学家和请求并尝试解释测试结果的临床医生都有兴趣。实验室科学家最终对这些测试结果负责,有责任提供准确和精确的结果,以使临床医生能够适当地管理患者,并避免需要重新采集和测试。此外,除非临床医生了解这些问题,否则他们将无法最好地诊断和管理他们的患者。

相似文献

1
Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis?实验室止血检测报告:减少止血诊断中分析后错误的最后机会?
Clin Chem Lab Med. 2010 Mar;48(3):309-21. doi: 10.1515/CCLM.2010.061.
2
Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis?分析前和分析后变量:止血诊断错误的主要原因?
Semin Thromb Hemost. 2008 Oct;34(7):612-34. doi: 10.1055/s-0028-1104540. Epub 2008 Dec 15.
3
Post-analytical Issues in Hemostasis and Thrombosis Testing.止血与血栓形成检测中的分析后问题
Methods Mol Biol. 2017;1646:545-559. doi: 10.1007/978-1-4939-7196-1_40.
4
Post-analytical Issues in Hemostasis and Thrombosis Testing: An Update.止血和血栓形成检测的分析后问题:更新。
Methods Mol Biol. 2023;2663:787-811. doi: 10.1007/978-1-0716-3175-1_53.
5
Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working group for Preanalytical Phase (WG-PRE).分析前质量改进。追求和谐,代表欧洲临床化学和实验室医学联合会(EFLM)分析前阶段工作组(WG-PRE)。
Clin Chem Lab Med. 2015 Feb;53(3):357-70. doi: 10.1515/cclm-2014-1051.
6
Internal quality control: best practice.内部质量控制:最佳实践。
J Clin Pathol. 2013 Dec;66(12):1027-32. doi: 10.1136/jclinpath-2013-201661. Epub 2013 Sep 26.
7
Patient safety and quality in laboratory and hemostasis testing: a renewed loop?实验室和止血检测中的患者安全和质量:一个新的循环?
Semin Thromb Hemost. 2012 Sep;38(6):553-8. doi: 10.1055/s-0032-1315960. Epub 2012 Jun 2.
8
Reference ranges of coagulation tests.
Methods Mol Biol. 2013;992:85-96. doi: 10.1007/978-1-62703-339-8_6.
9
Quality control in coagulation testing.凝血检测中的质量控制
Semin Thromb Hemost. 2008 Oct;34(7):642-6. doi: 10.1055/s-0028-1104542. Epub 2008 Dec 15.
10
ASVCP quality assurance guidelines: control of preanalytical and analytical factors for hematology for mammalian and nonmammalian species, hemostasis, and crossmatching in veterinary laboratories.美国兽医临床病理学家协会质量保证指南:兽医实验室中哺乳动物和非哺乳动物血液学、止血及交叉配血的分析前和分析因素控制
Vet Clin Pathol. 2012 Mar;41(1):8-17. doi: 10.1111/j.1939-165X.2012.00413.x.

引用本文的文献

1
Post-analytical Issues in Hemostasis and Thrombosis Testing: An Update.止血和血栓形成检测的分析后问题:更新。
Methods Mol Biol. 2023;2663:787-811. doi: 10.1007/978-1-0716-3175-1_53.
2
Hemostasis and Thrombosis: An Overview Focusing on Associated Laboratory Testing to Diagnose and Help Manage Related Disorders.止血与血栓形成:概述,重点介绍相关实验室检测,以诊断和帮助管理相关疾病。
Methods Mol Biol. 2023;2663:3-38. doi: 10.1007/978-1-0716-3175-1_1.
3
Croatian Society of Medical Biochemistry and Laboratory Medicine: National recommendations for blood collection, processing, performance and reporting of results for coagulation screening assays prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen and D-dimer.
克罗地亚医学生物化学和实验室医学学会:凝血筛选检测(凝血酶原时间、活化部分凝血活酶时间、凝血酶时间、纤维蛋白原和 D-二聚体)的血液采集、处理、性能和结果报告的国家建议。
Biochem Med (Zagreb). 2019 Jun 15;29(2):020503. doi: 10.11613/BM.2019.020503.
4
The new oral anticoagulants and the future of haemostasis laboratory testing.新型口服抗凝药物与止血实验室检测的未来。
Biochem Med (Zagreb). 2012;22(3):329-41. doi: 10.11613/bm.2012.035.